Lizbeth González-Herrera

Dr. Lizbeth González-Herrera

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2002 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
LGLizbeth González-Herrera
Lizbeth González-Herrera
GGG García‐Escalante
G García‐Escalante
ICI Castillo‐Zapata
I Castillo‐Zapata
JCJ Canto‐Herrera
J Canto‐Herrera
JCJ Ceballos‐Quintal
J Ceballos‐Quintal
LOL Orozco‐Orozco
L Orozco‐Orozco

10 December 2018 in American Journal of Human Biology
Verified
Journal Article
Closed access
PDF file
LGLizbeth González-Herrera
Lizbeth González-Herrera
JZJorge Zavala‐Castro
Jorge Zavala‐Castro
CAClaudia Ayala‐Cáceres
Claudia Ayala‐Cáceres
GPGerardo Pérez‐Mendoza
Gerardo Pérez‐Mendoza
MLMaría José López‐González
María José López‐González
AAAlberto Alcocer‐Gamboa
Alberto Alcocer‐Gamboa

3 August 2007 in Birth Defects Research Part A: Clinical and Molecular Teratology
Verified
Journal Article
Closed access
PDF file
LGLizbeth González-Herrera
Lizbeth González-Herrera
ICIleana Castillo‐Zapata
Ileana Castillo‐Zapata
GGGuadalupe Garcia‐Escalante
Guadalupe Garcia‐Escalante
DPDoris Pinto‐Escalante
Doris Pinto‐Escalante

23 November 2020 in American Journal of Human Biology
Verified
Journal Article
Closed access
PDF file
LGLarissa Michelle González‐Arce
Larissa Michelle González‐Arce
JLJulio César Lara‐Riegos
Julio César Lara‐Riegos
GPGerardo José Pérez‐Mendoza
Gerardo José Pérez‐Mendoza
RRRodrigo Rubí‐Castellanos
Rodrigo Rubí‐Castellanos
MVMiguel Vega‐Marcín
Miguel Vega‐Marcín
LGLizbeth González-Herrera
Lizbeth González-Herrera

1 January 2014 in Genetics & Epigenetics
Verified
Journal Article
Open access
GPGuillermo Valencia Pacheco
Guillermo Valencia Pacheco
DCDarig Cámara Cruz
Darig Cámara Cruz
LGLizbeth González-Herrera
Lizbeth González-Herrera
GMGerardo J. Pérez Mendoza
Gerardo J. Pérez Mendoza
GAGuadalupe I. Adrián Amaro
Guadalupe I. Adrián Amaro
ARAngélica V. Angulo Ramírez
Angélica V. Angulo Ramírez
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the production of autoantibodies against self-antigens, which occurs most often in women between 15 and 40 years of age. The innate immunity is involved in the pathogenesis of SLE through TLR-7. Genetic factors such as copy number variation (CNV) of target genes may contribute to disease development, but this possible risk has not yet been studied in SLE patients from Yucatan, Mexico. The CNV of TLR-7 gene was determined by quantitative polymerase chain reaction assay using TaqMan probes in 80 SLE women and 150 control subjects. The results showed that 10% of SLE patients exhibited more than two copies of TLR-7 gene, whereas no mRNA overexpression was detected. These data suggested that increased CNV of the TLR-7 gene in Yucatan SLE women can be a risk factor for this disease.

17 January 2022 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
GPGuillermo Valencia Pacheco
Guillermo Valencia Pacheco
YUYumi E. Nakazawa Ueji
Yumi E. Nakazawa Ueji
Julian Ramírez-BelloJulian Ramírez-Bello
Julian Ramírez-Bello
RBRosa Elda Barbosa-Cobos
Rosa Elda Barbosa-Cobos
EBEduardo D. Jiménez Becerra
Eduardo D. Jiménez Becerra
RVRicardo F. López Villanueva
Ricardo F. López Villanueva
Systemic Lupus Erythematosus (SLE) is an autoimmune disease in which genetic factors play a role in the susceptibility to develop it. Genes related to the synthesis of interferons such as TLR7 and genetics factors such as single nucleotide polymorphisms (SNPs) or copies number variation (CNV) in the gene have been involved with the development of the disease. The genetic differences between the populations contribute to the complexity of LES. Mexico has a mestizo population with a genetic load of at least three origins: Amerindian, Caucasian, and African. The mestizo of Yucatn is the only group whose contribution Amerindian is mainly Mayan, geographically distant from other Mexican Amerindians. We analyzed the CNV and the frequency of SNP rs179008 of the TLR7 as genetic risk factors in developing the disease in patients from Yucatn and Central Mexico. Results show that 14 of the cases of the Yucatecan population showed significantly 2 CNV and a higher risk of developing the disease (OR: 34.364), concerning 4 of those coming from Central Mexico (OR: 10.855). T allele and the A/T and T/T risk genotypes of rs179008 were more frequent in patients of Central Mexico than in those of Yucatn (50 vs. 30, 93 vs. 30, 4 vs. 1), and association with susceptibility to develop SLE was observed (OR: 1.5 vs. 0.58, 9.54 vs. 0.66, 12 vs. 0.14). Data support the genetic differences between and within Mexican mestizo populations and the role of the TLR7 in the pathogenesis of SLE.